NM_025074.7(FRAS1):c.9008A>C (p.Glu3003Ala) AND Fraser syndrome 1

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 17, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003143409.3

Allele description [Variation Report for NM_025074.7(FRAS1):c.9008A>C (p.Glu3003Ala)]

NM_025074.7(FRAS1):c.9008A>C (p.Glu3003Ala)

Gene:

FRAS1:Fraser extracellular matrix complex subunit 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

4q21.21

Genomic location:

Preferred name:

NM_025074.7(FRAS1):c.9008A>C (p.Glu3003Ala)

HGVS:

NC_000004.12:g.78496854A>C
NG_015812.2:g.444285A>C
NM_025074.7:c.9008A>CMANE SELECT
NP_079350.5:p.Glu3003Ala
NC_000004.11:g.79418008A>C

Protein change:

E3003A

Molecular consequence:

NM_025074.7:c.9008A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Fraser syndrome 1 (FRASRS1)
Synonyms:: Cryptophthalmos with other malformations
Identifiers:: MONDO: MONDO:0054737; MedGen: C4551480; Orphanet: 2052; OMIM: 219000

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003828361	Revvity Omics, Revvity	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jun 17, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003828361

Revvity Omics, Revvity

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Jun 17, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Nothing to display

Details of each submission

From Revvity Omics, Revvity, SCV003828361.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 16, 2024

ClinVar

Relating variation to medicine